Bruce C. Cozadd, Chairman & CEO at Jazz Pharmaceuticals plc (JAZZ), sold 1,500 shares at $123.43 ($185K) on 2025-01-02, disclosed to the SEC on 2025-01-06.
Seasonal sale ($185k) by Chairman & CEO — this insider has traded JAZZ in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| JAZZ | SELL | 2026-07-06 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-06-03 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-05-05 | $1.2M | — | Filing → |